Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Healthtrust
Teva
Chinese Patent Office
US Army
Dow
Chubb
Argus Health
Citi
Medtronic

Generated: August 20, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title:Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
Abstract: The invention relates to new heterocyclic compounds of general formula (I), and their salts with a base or an acid: ##STR00001## The invention also relates to a process for the preparation of these compounds as well as their use as medicaments, in particular as anti-bacterial agents.
Inventor(s): Lampilas; Maxime (Romainville, FR), Aszodi; Jozsef (Tucson, AZ), Rowlands; David Alan (Poissy, FR), Fromentin; Claude (Paris, FR)
Assignee: Aventis Pharma S.A. (Antony, FR)
Filing Date:Feb 06, 2006
Application Number:11/348,047
Claims:1. A process for the production of a compound of the formula ##STR00013## wherein R.sub.1 is --CONR.sub.6R.sub.7, R.sub.6 and R.sub.7, are individually selected from the group consisting of hydrogen, alkyl of 1 to 6 carbon atoms, aryl of 6 to 10 carbon atoms and aryl alkyl of 7 to 11 carbon atoms optionally substituted by carbamoyl, ureido or dimethylamino, and alkyl of 1 to 6 carbon atoms substituted by pyridyl, R.sub.2 is hydrogen, R.sub.3 is hydrogen, A is ##STR00014## R.sub.4, R.sub.4 is hydrogen, n'.sub.1 is 1 or 2, R.sub.5 is selected from the group consisting of --COOH, --CN, --OH, --NH.sub.2, --CONR.sub.6R.sub.7, --COOR, --OR, --OCOH, --OCOR, --OCOOR, --OCONHR, --OCONH.sub.2, --NHR, --NHCOH, --NHCOR, --NHSO.sub.2R, --NH--COOR, --NH--CO--NHR and --NHCONH.sub.2, R is selected from the group consisting of alkyl of 1 to 6 carbon atoms optionally substituted by pyridyl or carbamoyl, --CH.sub.2-alkenyl of 3 to 9 carbon atoms, aryl of 6 to 10 carbon atoms and aryl alkyl of 7 to 11 carbon atoms, with the aryl ring optionally substituted by a member of the group consisting of --OH, --NH.sub.2, --NO.sub.2, alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms and at least one halogen, R.sub.6 and R.sub.7 are defined as above, the dotted line is an optional bond, n is 1, X is --(CO)--B--, B is --NR.sub.8--(CH.sub.2).sub.n''-- attached to the carbonyl by the nitrogen, n'' is 0 or 1, R.sub.8 is selected from the group consisting of hydrogen, --OH, --R, --OR, --Y, --OY, --Y.sub.1, --OY.sub.1, --Y.sub.2, --OY.sub.2, Y.sub.3, --OCH.sub.2CH.sub.2SO.sub.mR, --OSiR.sub.aR.sub.bR.sub.c and --SiR.sub.aR.sub.bR.sub.c, R.sub.a, Rb, and Rc are alkyl of 1 to 6 carbon atoms or aryl of 6 to 10 carbon atoms, R is defined as above, m is 0 or 1 or 2, Y is selected from the group consisting of --COH, --COR, --COOR, --CONH.sub.2, --CONHR, --CONHOH, --CONHSO.sub.2R, --CH.sub.2COOH, --CH.sub.2COOR, --CH.sub.2CONHOH, --CH.sub.2CONHCN, --CH.sub.2SO.sub.3H, --CH.sub.2SO.sub.2R, --CH.sub.2PO(OR).sub.2, --CH.sub.2PO(OR)(OH), --CH.sub.2PO(R)(OH) and --CH.sub.2PO(OH).sub.2, Y.sub.1 is selected from the group consisting of --SO.sub.2R, --SO.sub.2NHCOH, --SO.sub.2NHCOR, --SO.sub.2NHCOOR, SO.sub.2NHCONHR, SO.sub.2NHCONH.sub.2 and --SO.sub.3H, Y.sub.2 is selected from the group consisting of --PO(OH).sub.2, --PO(OR).sub.2, --PO(OH)(OR) and --PO(OH)(R) and Y.sub.3 is selected from the group consisting of tetrazole, squarate, --NH, --NHSO.sub.2R and --NRSO.sub.2R and a salt with a base or an acid comprising at least the next two following steps: a) reacting a compound of the formula ##STR00015## R.sub.1 is defined as above, R.sub.2 is defined as above, A is defined as above, HZ is HNR'.sub.8--(CH.sub.2).sub.n''--, R'.sub.8 is selected from the group consisting of hydrogen, protected --OH, --R', OR', --Y', --OY', Y'.sub.1, OY'.sub.1, Y'.sub.2, OY'.sub.2, Y'.sub.3, Y' is selected from the group consisting of --COH, --COR', --COOR', --CONH.sub.2, --CONHR', --CONHOH, --CONHSO.sub.2R', --CH.sub.2COOH, --CH.sub.2COOR', --CH.sub.2CONHOH, --CH.sub.2CONHCN, CH.sub.2SO.sub.2R', --CH.sub.2PO(OR').sub.2, --CH.sub.2SO.sub.3, --CH.sub.2PO(OR')OH, --CH.sub.2PO(R')OH, --CH.sub.2PO(OH).sub.2, the carboxylic acid, hydroxyl and hydroxylamine groups of which being respectively protected in the form of i) alkyl, allyl, benzyl, benzhydryl and p-nitrobenzyl sters, ii) ethers, esters and carbonates, and iii) benzyl and allyl esters, Y'.sub.1 is selected from the group consisting of --SO.sub.2R', --SO.sub.2NHCOH, --SO.sub.2NHCOR', --SO.sub.2NHCOOR', --SO.sub.2NHCONH.sub.2, --SO.sub.2NHCONHR' and --SO.sub.3H, protected by branched alkyl of 3 to 6 carbon atoms, Y'.sub.2 is selected from the group consisting of --PO(OH).sub.2, --PO(OH)(OR'), --PO(OH)(R'), and --PO(OR').sub.2, the Hydroxy groups of which being protected in the form of esters, Y'.sub.3 is selected from the group consisting of --NH or --NR tetrazole substituted by R', --NHSO.sub.2R' and --NR'SO.sub.2R', n'' is defined as above, with a carbonylation agent selected from the group of phosgene, diphosgene, triphosgene, aryl chloroformates, aralkyl chloroformates, alkyl chloroformates, alkenyl chloroformates, alkyl dicarbonates, carbonyl-diimidazole and mixtures thereof optionally in the presence of a base, to obtain a compound of the formula ##STR00016## wherein either X.sub.1 is hydrogen and X.sub.2 is ZCOX.sub.3, X.sub.3 is the remainder of the carbonyl, or X.sub.1 is --COX.sub.3 and X.sub.2 is --ZH and X.sub.3 is as above, and b) cyclizing the compound of formula III in the presence of a base.

2. The process of claim 1 wherein the carbonylation is effected in the presence of a base.

3. The process of claim 2 wherein the base in an amine.

4. The process of claim 1 wherein in step b), the base is selected from the group consisting of amines, hydrides, alcoholates, amides and carbonates of alkali metal or alkaline earth metals.

5. The process of claim 1 for the production of a compound of formula (I) wherein Y.sub.1 is --SO.sub.3H and its salts further comprising a sulfatation step and optionally a salification step.

6. The process of claim 5 wherein the sulfatation is effected with --SO.sub.3-amine complex or --SO.sub.3-dimethylformamide in the presence of pyridine.

7. The process of claim 5 wherein salification is effected with an alkali metal salt, a quaternary ammonium salt or an amine salt.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Covington
Federal Trade Commission
Julphar
Boehringer Ingelheim
AstraZeneca
Citi
Fish and Richardson
Johnson and Johnson
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot